Journal ArticleBMJ · May 7, 2024
Polypharmacy is common in older adults and is associated with adverse drug events, cognitive and functional impairment, increased healthcare costs, and increased risk of frailty, falls, hospitalizations, and mortality. Many barriers exist to deprescribing, ...
Full textLink to itemCite
Journal ArticleJAMA health forum · May 2024
ImportanceComprehensive medication reviews (CMRs) are offered to qualifying US Medicare beneficiaries annually to optimize medication regimens and therapeutic outcomes. In 2016, Medicare adopted CMR completion as a Star Rating quality measure to e ...
Full textCite
Journal ArticleMed Care · April 1, 2024
OBJECTIVE: The association between participation in a behavioral weight intervention and health expenditures has not been well characterized. We compared Veterans Affairs (VA) expenditures of individuals participating in MOVE!, a VA behavioral weight loss ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · March 19, 2024
BACKGROUND: Transcatheter edge-to-edge repair (TEER) of mitral regurgitation is less invasive than surgery but has greater 5-year mortality and reintervention risks, and leads to smaller improvements in physical functioning. The study objective was to quan ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · March 2024
BACKGROUND: Anti-obesity medications (AOMs) can be initiated in conjunction with participation in the VA national behavioral weight management program, MOVE!, to help achieve clinically meaningful weight loss. OBJECTIVE: To compare weight change between Ve ...
Full textLink to itemCite
Journal ArticleJournal of the American Geriatrics Society · January 2024
AbstractBackgroundPotentially inappropriate medications (PIMs) in older adults are medications in which risks often outweigh benefits and are suggested to be avoided. Worldwide, many disti ...
Full textCite
Journal ArticleObes Res Clin Pract · 2024
The prevalence of overweight and obesity among military personnel has increased substantially in the past two decades. Following military discharge many personnel can receive integrated health care from the Veterans Health Administration. Prior research re ...
Full textLink to itemCite
Journal ArticleObes Res Clin Pract · 2024
OBJECTIVE: In a national cohort of Veterans, weight change was compared between participants in a US Department of Veterans Affairs (VA) behavioral weight management program (MOVE!) and matched non-participants, and between high-intensity and low-intensity ...
Full textLink to itemCite
Journal ArticleJAMA Surg · December 1, 2023
IMPORTANCE: Up to 40% of women experience dissatisfaction after breast reconstruction due to unexpected outcomes that are poorly aligned with personal preferences. Identifying what attributes patients value when considering surgery could improve shared dec ...
Full textLink to itemCite
Journal ArticleAnn Surg · October 1, 2023
OBJECTIVE: In a large multisite cohort of Veterans who underwent Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy, we compared the 5-year suicidal ideation and attempt rates with matched nonsurgical controls. BACKGROUND: Bariatric surgery has si ...
Full textLink to itemCite
Journal ArticleJCO Clin Cancer Inform · September 2023
PURPOSE: Several novel therapies for castration-resistant prostate cancer (CRPC) have been approved with randomized phase III studies with continuing observational research either planned or ongoing. Accurately identifying patients with CRPC in electronic ...
Full textLink to itemCite
Journal ArticleJournal of the American Geriatrics Society · June 2023
This editorial comments on the article by Niznik et al. in this issue. ...
Full textCite
Journal ArticleJ Gen Intern Med · May 2023
BACKGROUND: Obesity (body mass index [BMI]≥30kg/m2) among US adults has tripled over the past 45 years, but it is unclear how this population-level weight change has occurred. OBJECTIVE: We sought to identify distinct long-term BMI trajectories and examine ...
Full textLink to itemCite
Journal ArticlePloS one · January 2023
BackgroundInsurers manage the cost of specialty medicines via rebates, however it is unclear if the savings are passed on to patients, and whether reducing rebates may lead to changes in patient out-of-pocket (OOP) costs and medication adherence. ...
Full textCite
Journal ArticleOphthalmol Glaucoma · 2023
OBJECTIVE: To evaluate the cost utility of a glaucoma medication-enhancing intervention compared to standard of care over a lifetime from the United States Department of Veterans Affairs (VA) payer perspective. DESIGN: Model-based cost-utility analysis of ...
Full textLink to itemCite
Journal ArticleSemin Oncol · 2023
INTRODUCTION: In 2016, the Department of Veterans Affairs (VA) and Prostate Cancer Foundation (PCF) began a partnership to improve access to testing. The primary objective of this analysis was to describe the use of tumor testing and treatment patterns in ...
Full textLink to itemCite
Journal ArticleAm J Ophthalmol · December 2022
PURPOSE: To assess the within-trial cost-effectiveness of a behavioral intervention to improve glaucoma medication adherence. DESIGN: Prospective cost-effectiveness analysis of randomized, controlled trial data. METHODS: The study setting was a Veterans Af ...
Full textOpen AccessLink to itemCite
Journal ArticleJAMA Cardiol · September 1, 2022
IMPORTANCE: In the setting of uncertain efficacy and additional, unreimbursed cost, use of an embolic protection device (EPD) during transcatheter aortic valve replacement (TAVR) has had variable uptake. The Centers for Medicare & Medicaid Services (CMS) i ...
Full textLink to itemCite
Journal ArticleVaccine · August 19, 2022
BACKGROUND: Achieving high COVID-19 vaccination rates among employees is necessary to prevent outbreaks in health care settings. The goal of the study was to produce actionable and timely evidence about factors underlying the intention and decisions to obt ...
Full textOpen AccessLink to itemCite
Journal ArticleGeriatrics (Basel) · May 19, 2022
Deprescribing may be particularly beneficial in patients with medical complexity and suspected cognitive impairment (CI). We describe central nervous system (CNS) medication use and side effects in this population and explore the relationship between antic ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · October 2021
BACKGROUND: In 2014, qualified health plans sold in the Affordable Care Act (ACA) marketplaces were accused of providing drug coverage that was too restrictive and costly. After the change in administration in 2016, efforts to repeal portions of the ACA le ...
Full textLink to itemCite
Journal ArticleJ Allergy Clin Immunol Pract · September 2021
BACKGROUND: Recently developed peanut desensitization treatment reduces the incidence of allergic reactions, the anxiety associated with the risk of accidental exposure, and the burden of precautionary behavior. Eliciting parent preferences for tradeoffs i ...
Full textLink to itemCite
Journal ArticleBMC Cancer · July 16, 2021
BACKGROUND: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States (US). Among VHA patients, the rate of use of concurrent chemoradiation therapy (CCRT) among those with unresectable, stage III non-small ...
Full textLink to itemCite
Journal ArticleArch Phys Med Rehabil · July 2021
OBJECTIVE: To examine use, costs, and value of physical therapy (PT) among subgroups. DESIGN: We conducted an observational study of data from a randomized trial of a pain coping skills intervention. Good and poor outcome subgroups were determined based on ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · July 2021
BACKGROUND: The prevalence of financial medication assistance (FMA), including patient assistance programs, coupons/copayment cards, vouchers, discount cards, and programs/pharmacy services that help patients apply for such programs, has increased. The imp ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Trials · June 2021
BACKGROUND: Glaucoma treatment requires patients to follow daily, often times complex, eye drop regimens, but adherence is poor for many patients, putting them at risk for irreversible vision loss. A comprehensive approach is needed to address the challeng ...
Full textOpen AccessLink to itemCite
Journal ArticleMed Care · May 1, 2021
OBJECTIVE: Population segmentation has been recognized as a foundational step to help tailor interventions. Prior studies have predominantly identified subgroups based on diagnoses. In this study, we identify clinically coherent subgroups using social dete ...
Full textLink to itemCite
Journal ArticleCancer Treat Res Commun · 2021
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation testing is recommended in metastatic non-small cell lung cancer (NSCLC). The objective of this study was to assess changes in EGFR mutation testing patterns and tyrosine kinase inhibitor (TKI) us ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · December 2020
BACKGROUND: Tenofovir alafenamide (TAF) is a new formulation of tenofovir disoproxil fumarate (TDF) that was approved in 2015. While clinical trial evidence suggests that TAF has more favorable outcomes related to kidney injury and loss of bone mineral den ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials Commun · September 2020
Multi-site clinical trials are essential within medical practice to help drive reliable and generalizable knowledge on advancing medical treatments. Although the success of multi-site trials is significantly dependent on local clinician and site research t ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials Commun · September 2020
UNLABELLED: Protocol adherence in behavioral intervention clinical trials is critical to trial success. There is increasing interest in understanding which patients are more likely to adhere to trial protocols. The objective of this study was to demonstrat ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · July 2020
The number of people in the United States living with Alzheimer disease (AD) is growing, resulting in significant clinical and economic impact. Substantial research investment has led to drug development in stages of AD before symptomatic dementia, such as ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · March 1, 2020
OBJECTIVES: Cost-effectiveness estimates are useful to a health plan when they are specific to a utilization management policy question. To help inform a step therapy policy decision, this study assessed the 3-year cost-effectiveness of adding a sodium-glu ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · February 2020
BACKGROUND: Concurrent use of opioids and benzodiazepines is associated with increased risk of opioid overdose and death. Clinical guidelines recommend against this practice and quality measures incentivize plans to minimize concurrent use. OBJECTIVE: To c ...
Full textLink to itemCite
Journal ArticleOsteoarthritis Cartilage · October 2019
OBJECTIVES: This study examined ninety-day and one-year postoperative healthcare utilization and costs following total knee arthroplasty (TKA) from the health sector and patient perspectives. DESIGN: This study relied on: 1) patient-reported medical resour ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · August 2019
BACKGROUND: There is a paucity of studies validating budget impact models. The lack of such studies may contribute to the underuse of budget impact models by payers in formulary decision making. OBJECTIVE: To assess the face validity, internal verification ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · August 2019
Historically, budget impact models have been used to demonstrate how a new drug or technology entering the market could influence payer budgets, with the hope of influencing coverage of the drug or technology. This article proposes the adaptation of a budg ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · May 2019
Managed care organizations are growing more sophisticated in their ability to analyze data. There are increasing numbers of data analysts at managed care organizations, as well as more types of real-time, or "live," data available. These data range from ph ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · March 2019
BACKGROUND: Traditional budget impact models predict the financial consequences of a new drug entering the market. This study provides an example of applying the budget impact framework to a new research question of interest to managed care organizations-w ...
Full textLink to itemCite
Journal ArticleJ Am Pharm Assoc (2003) · 2019
OBJECTIVES: To evaluate the degree to which health care professionals and patients receive consistent messages regarding the possible harms of statins. DESIGN: Cross-sectional study of prescribing information (PI), patient package inserts (PPIs), and pharm ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · December 2017
BACKGROUND: Biosimilars undergo an abbreviated licensure pathway called 351(k), which was created by the Biologics Price Competition and Innovation Act of 2009. This approval process is different from the 351(a) pathway for original biologic approval and, ...
Full textLink to itemCite
Journal ArticleJ Manag Care Spec Pharm · July 2016
BACKGROUND: Medicare Prescription Drug Plans (PDPs) do not have incentives to consider long-term outcomes and costs associated with both medical and pharmacy benefits (LTOCMP) when making formulary decisions. OBJECTIVE: To identify existing quality measure ...
Full textLink to itemCite
Journal ArticleOncologist · June 2016
BACKGROUND: We explored biologics receipt in metastatic colon cancer. METHODS: We used Surveillance, Epidemiology, and End Results-Medicare data of 4,545 elderly patients diagnosed with incident metastatic colon cancer from 2003 to 2009, treated with chemo ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · February 1, 2016
OBJECTIVES: To compare the rates of mammographic screening and reasons for not receiving mammography between Medicare Advantage (MA) and Medicare fee-for-service (FFS) beneficiaries. STUDY DESIGN: Cross-sectional study. METHODS: Unadjusted rates of mammogr ...
Link to itemCite
Journal ArticleInt J STD AIDS · June 2015
To examine approaches being used to evaluate and improve quality of HIV clinical services we searched the MEDLINE, Cochrane Library collection, EMBASE, Global Health, and Web of Science databases for articles and abstracts focused on evaluating or improvin ...
Full textLink to itemCite
Journal ArticleExpert Rev Clin Pharmacol · March 2014
Painful diabetic peripheral neuropathy is difficult to treat, partially because the underlying mechanism of pain is not fully understood. Various treatment guidelines recommend first-line agents, such as α2-δ ligands, serotonin-norepinephrine reuptake inhi ...
Full textLink to itemCite
Journal ArticleOncologist · 2013
BACKGROUND: Chemotherapy effectiveness in clinical practice may differ from the efficacy demonstrated in clinical trials, particularly among populations underrepresented in clinical trials, such as elderly patients with cancer. This review aims to examine ...
Full textLink to itemCite